APTO•benzinga•
HC Wainwright & Co. Maintains Buy on Aptose Biosciences, Raises Price Target to $6
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 28, 2025 by benzinga